MMIT is powered by NorstellaLinQ, pharma’s first fully linked and integrated data asset. Strengthen your market access strategy with data that’s unparalleled in breadth and relevance, with open and closed claims, lab tests and results, electronic medical records, coverage data and more.
Powered by NorstellaLinQ, MMIT helps you track a patient cohort from diagnosis to treatment, noting the critical events and triggers along the way—from test results to payer restrictions that impact provider behavior.
Business Questions
Business Questions
Business Questions
Norstella’s real-world data specialists have extensive experience in leveraging structured and unstructured healthcare data to power insights across commercial, medical affairs, HEOR, and clinical trial engagement.
With NorstellaLinQ, MMIT delivers clarity, confidence, and speed with tailored solutions. Whether you’re a fast-growing biotech or an industry leader, our expert support empowers you to strengthen your strategy, act faster, and achieve better outcomes.
Patients who have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer over a given time period.
Patients who have successfully completed a frontline platinum-based regimen.
Patients who are in remission and haven’t moved on to a second therapy.
Patients in remission who are actively being managed and maintain levels through lab testing (Cancer Antigen / CA 125).
Eligible patients at Texas Oncology.
Data is only powerful when it’s actionable. See how MMIT analyzes massive real-world datasets and translates the results into information your team can use.
Learn about NorstellaLinQ, your all-in-one, fully linked, clinically-validated real-world data ecosystem. It combines open and closed claims, structured and unstructured EMRs, lab results, SDOH, and mortality data into a single, expertly curated asset.
Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.
Real-world data (RWD) refers to healthcare information collected outside of traditional clinical trials. It includes data from electronic health records (EHRs), insurance claims, patient registries, wearables, and other real-world sources.
RWD provides insights into how therapies perform in everyday clinical practice. It helps pharmaceutical companies, payers, and providers make evidence-based decisions, improve patient outcomes, and support market access and reimbursement strategies.
Clinical trial data is collected in controlled, experimental settings, while RWD reflects actual patient experiences in real-world healthcare environments, capturing broader populations, adherence patterns, and long-term outcomes.
Common RWD sources include:
Companies use RWD to:
RWD is the raw healthcare data collected from real-world sources, while real-world evidence (RWE) is the analysis and insights derived from RWD to support clinical, regulatory, and commercial decisions.
Challenges include data quality and completeness, interoperability between systems, privacy and compliance concerns, and the need for robust analytical methods to generate reliable insights.
RWD Visualizations
This solution combines coverage, claims and pathways data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
RWD Insights
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.
Our RWD powered solutions use mastered, linked and tokenized data assets to deliver clear insights across the patient journey.
